首页> 外文期刊>International journal of clinical oncology >The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers
【24h】

The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers

机译:改良的格拉斯哥预后评分(mGPS)可很好地预测无法切除的胰腺癌和胆道癌患者姑息性旁路手术的适应症

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Patients with unresectable pancreatic and biliary cancers sometimes need decompression due to obstruction of the gastrointestinal tract and/or biliary tract. The aim of this study was to determine the prognostic factors associated with an indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers. Methods: Between April 2005 and September 2011, 37 patients with unresectable pancreatic and biliary cancers underwent palliative bypass surgery. Prognostic factors were searched for among clinical characteristics, operation-related factors, and tumor-related factors using a prospective database. Results: The median survival time (MST) of these patients was 4.6 months, with a 6-month survival rate of 40.5 %. A multivariate Cox proportional hazards regression analysis revealed that mGPS >2 was the only independent prognostic factor for bypass surgery. Patients with an mGPS of 2 had an MST of 1.7 months, and they had a significantly worse prognosis than mGPS 0-1 patients with an MST of 6.3 months. Conclusions: The mGPS is useful for predicting survival after surgical decompression due to gastrointestinal obstruction in patients with unresectable pancreatic and biliary cancers. Patients with a poor mGPS may not be indicated for palliative bypass surgery.
机译:背景:不可切除的胰腺癌和胆道癌患者有时会因胃肠道和/或胆道阻塞而需要减压。这项研究的目的是确定与不可切除的胰腺癌和胆道癌患者姑息性旁路手术适应症相关的预后因素。方法:2005年4月至2011年9月,对37例无法切除的胰腺癌和胆道癌患者进行姑息旁路手术。使用前瞻性数据库在临床特征,手术相关因素和肿瘤相关因素中搜索预后因素。结果:这些患者的中位生存时间(MST)为4.6个月,6个月生存率为40.5%。多元Cox比例风险回归分析显示,mGPS> 2是旁路手术的唯一独立预后因素。 mGPS为2的患者的MST为1.7个月,与mGPS为6.3个月的mGPS 0-1的患者相比,他们的预后明显更差。结论:mGPS可用于预测不可切除的胰腺癌和胆道癌患者因胃肠道阻塞而进行的手术减压后的存活率。 mGPS差的患者可能不适合姑息性旁路手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号